Abstract
Background Understanding disease progression, age-specific comorbidities, medical treatment patterns, and unmet needs can help improve the care pathway of individuals with rare genetic epilepsies. A matched longitudinal cohort study has not been performed for these variables from childhood to adolescence across the whole phenome.
Methods We identified individuals with likely genetic and non-genetic epilepsy syndromes and onset at ages 0-5 years by linkage across the Cleveland Clinic Health System. We used natural language processing to extract medical terms and procedures from longitudinal electronic health records (EHR) and tested for cross-sectional and temporal associations with genetic epilepsies.
Findings We identified 503 individuals with genetic epilepsy syndromes and matched controls with epilepsy that did not receive genetic testing. The median age at the first encounter was 0·1 years, 7·9 years at the last encounter, and the mean duration of follow-up was 8·2 years. We extracted 188,295 Unified Medical Language System (UMLS) annotations for statistical analysis across 9,659 encounters. Individuals with genetic epilepsy syndromes received an earlier epilepsy diagnosis and had more frequent and complex encounters with the healthcare system. Notably, the highest enrichment of encounters compared to the non-genetic groups was found during the transition from paediatric to adult care. Our computational approach could validate established comorbidities of genetic epilepsies, such as behavioural abnormality and intellectual disability. We also revealed novel associations for genitourinary abnormalities (OR 1·91, 95% CI: 1·66-2·19, p = 2·39×10-19) linked to a spectrum of underrecognized genetic syndromes.
Interpretation This study identified novel features associated with the likelihood of a genetic epilepsy syndrome and quantified the healthcare utilization of genetic epilepsies compared to matched controls with epilepsy who did not receive genetic testing. Our results strongly recommend early genetic testing to stratify individuals into specialized care paths, thus improving the clinical management of people with genetic epilepsies.
Funding Not applicable.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
IRB of Cleveland Clinic gave ethical approval for this work (ID #22-147 and #23-253).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Deidentified individual participant data can be made available upon reasonable requests submitted to the corresponding author. The prerequisite for data sharing is a data transfer agreement approved by the legal departments and institutional review board of the requesting researcher. After proposal approval, data can be shared through a secure online platform. All code used for data analysis and visualization is available at https://github.com/christianbosselmann/UMLS-HPO.
Abbreviations
- ASM
- anti-seizure medication
- CPT
- Current Procedural Terminology
- DEE
- developmental and epileptic encephalopathies
- EEG
- electroencephalography
- EHR
- electronic health records
- HPO
- human phenotype ontology
- ICD
- International Classification of Diseases
- ILAE
- International League Against Epilepsy
- NLP
- natural language processing
- UMLS
- Unified medical language system
- quantile-quantile
